Euromonitor International, April 2011, Pages: 35
Cough, Cold and Allergy (Hay Fever) Remedies in the United KingdomIn 2010 the coughcold and allergies environment grew by more than 2% in current value terms to reach a value of £637 million. The
Nicholas Hall Group, Oct 2010, Pages: 319
comprehensive report scrutinises CCA brands and marketers in the leading developed and emerging markets. Strategic analysis defines and explores the trends and developments affecting OTC cough, cold & allergy
Global Industry Analysts, Inc., Feb 2010, Pages: 873
Players III-35
B.Market Analytics III-36
Table 35: The UKRecent Past, Current & Future Analysis for
Cold, Cough and Sore Throat Remedies - Annual Sales Figures
inUS$ Million for Years 2006 through 2015
Euromonitor International, July 2011, Pages: 34
Cough, Cold and Allergy (Hay Fever) Remedies in Thailand Sales of coughcold and allergy (hay fever) remedies grew 8% in 2010 due to some enabling factors such as fluctuations in the domestic climate
Euromonitor International, April 2011, Pages: 37
Cough, Cold and Allergy (Hay Fever) Remedies in Ireland 2010 began as the coldest winter in living memory for most people in Ireland, as it was certainly the coldest since 1967, with night time
Euromonitor International, March 2010, Pages: 54
Cough, Cold and Allergy (hay Fever) Remedies in India 2009 witnessed a diminished monsoon season and drought-like conditions in many parts of India. However, sales of cough, cold and allergy remedies
Global Industry Analysts, Inc., April 2011, Pages: 1088
UCB Launch Prescription Allergy Drug,
Xyzal® in the US 63
FDA Clears Veramyst™ Nasal Spray for Treating Allergy 64
7. DRUG PIPELINE ANALYSIS 65
Table 2: Pediatric Drugs Pipeline By Select Disease
Euromonitor International, April 2011, Pages: 27
Wound Care in the United KingdomIn 2010 wound treatments declined 5% in current value terms to a value of £59 million. The industry has responded to strong private label competition in the past few
Euromonitor International, April 2011, Pages: 26
Calming and Sleeping in the United KingdomIn 2010 calming and sleeping products increased by 4% to reach a value of £42 million. This category was driven mainly by the introduction of herbal
Euromonitor International, April 2011, Pages: 25
Ear Care in the United Kingdom The ear care category reached £10 million in 2010, showing strong growth of 8% that year. This growth was underpinned by new product launches, such as Cerumol Olive Oil
Euromonitor International, April 2011, Pages: 23
OTC Triptans in the United KingdomIn 2010 sales of OTC triptans were worth approaching £5 million, up 35% in current terms on 2009. Migraines already affect 15% of adults in the UK, equivalent to
Euromonitor International, April 2011, Pages: 23
Emergency Contraception in the United KingdomIn 2010 the emergency contraception category increased by 8% to reach a total sales value of £22 million. Sales were mainly attributable to the Levonelle
Euromonitor International, April 2011, Pages: 38
than in 2003 due to a milder winter, which meant there were fewer outbreaks of colds and flu. As a result the largest sectors, analgesics and cough, cold and allergy (hay fever) remedies, recorded
Euromonitor International, April 2011, Pages: 29
Digestive Remedies in the United KingdomIn 2010 the digestive remedies category in the UKdeclined marginally to reach retail value sales of £291 million. The home-cooking trend and the general move
Euromonitor International, April 2011, Pages: 27
Eye Care in the United KingdomIn 2010 eye care sales in the UKwere worth more than £55 million, up 9% on 2009. Introducing more sophisticated segmentation, such as products for dry eyes, tired eyes
Global Industry Analysts, Inc., Jan 2011, Pages: 378
24
Table 4: US Market for Nasal Sprays: Top Five Nasal Sprays
for Cough, Cold, Sinus and Allergy Ranked by Dollar Retail
Sales for the Year Ended January 2008 (InUS
Euromonitor International, April 2011, Pages: 31
Adult Mouth Care in the United KingdomIn 2010 adult mouth care achieved sales worth £32 million, down 2% in current value terms on 2009. Although a decline in sales value, the rate of decline was
ICON Group International, Jan 2011, Pages: 186
).
The latent demand for cough, cold, and allergy remedies is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either lower or higher than actual sales
